News

There are problems with generative AI, and there need to be guardrails and there needs to be human oversight," said Jason ...
FDA staffers in the Center for Devices and Radiological Health told NBC News that their AI pilot, CDRH-GPT, is buggy, isn't ...
FDA employees report the agency's new AI assistant produces incorrect answers and lacks essential safeguards. (Shutterstock) ...
Dubbed Elsa, the tool was expected to roll out at the end of June. The FDA says it marks the dawn of a new era.
Tonight’s the premiere of Dimension 20’s steampunk-themed Cloudward, Ho! series. I’m excited; anyone else? (If you’re ...
The Food and Drug Administration has officially launched "Elsa," a generative artificial intelligence platform designed to ...
The FDA launched an artificial intelligence tool Monday dubbed Elsa, with Commissioner Marty Makary hyping the effort’s early ...
AI-driven Clairity Breast platform, now FDA-approved, predicts five-year breast cancer risk from mammograms, enhancing early ...
The FDA is using Elsa to accelerate clinical protocol reviews, shorten the time needed for scientific evaluations and identify high-priority inspection targets.
The FDA is moving quickly to bring artificial intelligence (AI) into the heart of its regulatory review process. On May 8, ...
FDA announced the launch of Elsa, a generative artificial intelligence (AI) tool designed to help employees from scientific ...
Following a successful pilot, the Food and Drug Administration unveiled its in-house large language model designed to help ...